Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain
- 19 August 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 17 (19) , 6983-6992
- https://doi.org/10.1016/j.bmc.2009.08.022
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- In vitro and In vivo Activity of Novel Small-Molecule Inhibitors Targeting the Pleckstrin Homology Domain of Protein Kinase B/AKTCancer Research, 2009
- Membrane recognition by phospholipid-binding domainsNature Reviews Molecular Cell Biology, 2008
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Antitumor Agents 252. Application of validated QSAR models to database mining: discovery of novel tylophorine derivatives as potential anticancer agentsJournal of Computer-Aided Molecular Design, 2007
- The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB dataNucleic Acids Research, 2006
- A Novel Automated Lazy Learning QSAR (ALL-QSAR) Approach: Method Development, Applications, and Virtual Screening of Chemical Databases Using Validated ALL-QSAR ModelsJournal of Chemical Information and Modeling, 2006
- Development of Quantitative Structure−Binding Affinity Relationship Models Based on Novel Geometrical Chemical Descriptors of the Protein−Ligand InterfacesJournal of Medicinal Chemistry, 2006
- Exploiting the PI3K/AKT Pathway for Cancer Drug DiscoveryNature Reviews Drug Discovery, 2005
- PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculationsNucleic Acids Research, 2004